Why Freshworks Stock Bumped Higher Today
It'll replace a healthcare company that's being acquired. The "index effect" was in play after the announcement.
Stock Taper
Freshworks Inc., founded in 2010 and headquartered in San Mateo, California, offers global SaaS software products and was formerly known as Freshdesk Inc. until rebranding in June 2017.

A standalone service management platform for non-IT departments like HR, finance, and legal, enhancing internal processes and service delivery across enterprises, expanding Freshworks' market reach.
Freshworks Inc. reported strong financial results for the first quarter of 2025, surpassing analyst expectations for both earnings per share and revenue. The company announced a 19% year-over-year revenue increase to $196.3 million and an expanded non-GAAP operating margin, leading to a significant rally in its stock price in after-market trading.
Freshworks is making a significant strategic pivot by positioning artificial intelligence, specifically agentic AI, as its primary growth catalyst. The company is developing its own AI stack using multiple foundation models to create autonomous agents capable of executing complex workflows, aiming to transform both customer and employee service experiences.
It'll replace a healthcare company that's being acquired. The "index effect" was in play after the announcement.
Freshworks Inc. (NASDAQ: FRSH - Get Free Report)'s stock price reached a new 52-week high during mid-day trading on Tuesday. The stock traded as high as $14.37 and last traded at $13.9760, with a volume of 1798559 shares traded. The stock had previously closed at $13.22. Wall Street Analyst Weigh In A number of research firms
U.S. stocks were higher, with the Dow Jones index surging over 250 points on Tuesday.
NEW YORK, Oct. 5, 2026 /PRNewswire/ -- Freshworks Inc. (NASD: FRSH) will replace BioLife Solutions Inc. (NASD:BLFS) in the S&P SmallCap 600 effective prior to the open of trading on Thursday, October 8. S&P MidCap 400 constituent Repligen Corp. (NASD:RGEN) is acquiring BioLife Solutions in a deal expected to be completed soon, pending final closing conditions.
Overall rating: A
| PEER | PRICE | |
|---|---|---|
CRM | $225.70 | COMPARE |
HUBS | $221.45 | COMPARE |
GBTG | $9.50 | COMPARE |
DAVE | $346.94 | COMPARE |
BRZE | $26.31 | COMPARE |
INTA | $36.99 | COMPARE |
KC | $9.44 | COMPARE |
PTRN | $17.75 | COMPARE |